Literature DB >> 21151033

The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Nicole Baumgarth1.   

Abstract

During their development, B and T cells with self-reactive antigen receptors are generally deleted from the repertoire to avoid autoimmune diseases. Paradoxically, innate-like B-1 cells in mice are positively selected for self-reactivity and form a pool of long-lived, self-renewing B cells that produce most of the circulating natural IgM antibodies. This Review provides an overview of the developmental processes that shape the B-1 cell pool in mice, outlines the functions of B-1 cells in both the steady state and during host defence, and discusses possible functional B-1 cell homologues that exist in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21151033     DOI: 10.1038/nri2901

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  149 in total

Review 1.  B-1 cells: the lineage question revisited.

Authors:  L A Herzenberg
Journal:  Immunol Rev       Date:  2000-06       Impact factor: 12.988

2.  The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen.

Authors:  Michael J Chumley; Joseph M Dal Porto; John C Cambier
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

3.  Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors.

Authors:  Joseph R Tumang; Rubén Francés; Seung Geun Yeo; Thomas L Rothstein
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

4.  CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells.

Authors:  G Bikah; J Carey; J R Ciallella; A Tarakhovsky; S Bondada
Journal:  Science       Date:  1996-12-13       Impact factor: 47.728

5.  B1 and B2 cells differ in their potential to switch immunoglobulin isotype.

Authors:  D M Tarlinton; M McLean; G J Nossal
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

6.  Ontogeny of terminal deoxynucleotidyl transferase-positive cells in lymphohemopoietic tissues of rat and mouse.

Authors:  K E Gregoire; I Goldschneider; R W Barton; F J Bollum
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

7.  Adult BM generates CD5+ B1 cells containing abundant N-region additions.

Authors:  Nichol E Holodick; Karen Repetny; Xuemei Zhong; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

8.  The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production.

Authors:  Byoung-gon Moon; Satoshi Takaki; Kensuke Miyake; Kiyoshi Takatsu
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

9.  B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.

Authors:  Hedda Wardemann; Thomas Boehm; Neil Dear; Rita Carsetti
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

10.  B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion.

Authors:  David Savitsky; Kathryn Calame
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

View more
  409 in total

1.  A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Authors:  Hiroaki Kaku; Kai Fan Cheng; Yousef Al-Abed; Thomas L Rothstein
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

Authors:  Amador Goodridge; Carla Cueva; Maureen Lahiff; Grace Muzanye; John L Johnson; Payam Nahid; Lee W Riley
Journal:  Tuberculosis (Edinb)       Date:  2012-03-10       Impact factor: 3.131

3.  Developmental relationships between B-1 and B-2 progenitors.

Authors:  Chad L Barber; Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 4.  Regulation of mucosal IgA responses: lessons from primary immunodeficiencies.

Authors:  Andrea Cerutti; Montserrat Cols; Maurizio Gentile; Linda Cassis; Carolina M Barra; Bing He; Irene Puga; Kang Chen
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

Review 5.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

6.  Antigen-specific antibody responses in B-1a and their relationship to natural immunity.

Authors:  Yang Yang; Eliver Eid Bou Ghosn; Leah E Cole; Tetyana V Obukhanych; Patricia Sadate-Ngatchou; Stefanie N Vogel; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-14       Impact factor: 11.205

7.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

8.  FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Authors:  Sudhir Gupta; Sudhanshu Agrawal; Sastry Gollapudi; Hiromi Kubagawa
Journal:  Hum Immunol       Date:  2016-10-14       Impact factor: 2.850

9.  Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling.

Authors:  Y-S Jang; G-Y Seo; J-M Lee; H-Y Seo; H-J Han; S-J Kim; B-R Jin; H-J Kim; S-R Park; K-J Rhee; W-S Kim; P-H Kim
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

10.  Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses.

Authors:  Gaetan Barbet; Leif E Sander; Matthew Geswell; Irina Leonardi; Andrea Cerutti; Iliyan Iliev; J Magarian Blander
Journal:  Immunity       Date:  2018-03-13       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.